Figure 4

Pathways that modulate mitochondrial reactive oxygen species. Hypoxia, activation of oncogenes, mitochondrial DNA mutations, and loss of tumor suppressors have all been shown to lead to a mitochondrial ROS dependent increases in tumorigenesis.